₈J Satsangi

Summary for 2004 [at-glance overview of J Satsangi work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author J Satsangi. According to available data, in 2004 J Satsangi published at least 8 articles. This work was completed in collaboration with several authors including Russell, R K and Wilson, D C. Many other authors have collaborated with J Satsangi as well. There is no information about the funding or the grants awarded to support this work.

J Satsangi has rank 6 when compared to all other authors using the keyword Nod2 Signaling Adaptor Protein. Analysis of the article abstracts and the titles suggests that J Satsangi professional interests are focused around "inflammatory bowel disease", "severe ulcerative colitis" and "heterogeneity within europe". These might also be referred to as "inflammatory bowel", "bowel disease" or "crohn disease". Statistical analysis shows that J Satsangi's writing is likely to contains terms "disease", "mutations", "inflammatory", "bowel", "patients" and "ibd".

Unfortunately, there is not enough information to establish J Satsangi affiliation. Luckily, several email addresses are on file.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for J Satsangi]

Do you know J Satsangi who matches the profile above? Click the photo and let us know!

Alternative names (1) [other authors with names similar to J Satsangi]

₅₃Satsangi, Jack

Year 2004 Charts [J Satsangi frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of J Satsangi publication and funding history for the range of years]

Emails (4) [email addresses extracted from J Satsangi affiliations]

hidden to prevent spam, click here to reveal

J Satsangi Coauthors (23) [all coauthors with the number of joint publications]

4

3

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

Other [context-specific ads]

Affiliations (7) [condensed summary of the J Satsangi affiliations, the leading number and the color conveys importance]

₁Gastrointestinal Unit and Department of Child life and Health, University of Edinburgh, Edinburgh, Scotland.
₁Gastrointestinal Unit, University Department of Medical Sciences, University of Edinburgh, Western General Hospital, Edinburgh, UK.
₁Gastrointestinal Unit, University of Edinburgh, Department of Medical Sciences, Edinburgh, UK .
₁Department of Medical Sciences, Gastrointestinal Unit, University of Edinburgh, Edinburgh EH4 2XU, UK.
₁University Department of Gastroenterology, Western General Hospital, Edinburgh EH4 2XU, Scotland, UK.
₁Cancer Research UK Cell Structure Research Group, School of Life Science, University of Dundee, Dundee, DD1 5EH, UK.
₁Gastrointestinal Unit, University of Edinburgh School of Clinical and Molecular Medicine, Western General Hospital, Edinburgh, UK.

Key Opinion Leader In [J Satsangi is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

₆Nod2 Signaling Adaptor Protein | ₁₂Crohn Disease | ₂₇Colitis, Ulcerative | ₉₈Intracellular Signaling Peptides and Proteins | ₂₇₀Mutation | ₂₇₈Phenotype

Keywords (32) [keywords assigned to J Satsangi articles by PubMed, the leading number and the color conveys importance]

₇Humans | ₆Crohn Disease | ₅Mutation | ₄Colitis, Ulcerative | ₃Nod2 Signaling Adaptor Protein | ₃Adult | ₃Female | ₃Phenotype | ₃Male | ₃Intracellular Signaling Peptides and Proteins | ₂Genotype | ₂Carrier Proteins | ₂Inflammatory Bowel Diseases | ₂Gene Frequency | ₂Middle Aged | ₁Base Sequence | ₁Adolescent | ₁Sensitivity and Specificity | ₁Family Health | ₁Follow-Up Studies | ₁Cell Differentiation | ₁Immunosuppressive Agents | ₁Scotland | ₁Anticipation, Genetic | ₁Regression Analysis | ₁Membrane Glycoproteins | ₁Microfilaments | ₁Chromosomes, Human, Pair 12 | ₁Keratin-8 | ₁Linkage (Genetics) | ₁Xenopus | ₁Receptors, Cell Surface

J Satsangi Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; J Satsangi might be a good expert witness on these terms]

₂₅disease | ₁₁mutations | ₁₀inflammatory | ₁₀bowel | ₁₀patients | ₉ibd | ₈crohn | ₈risk | ₇keratin | ₆card15 | ₆nod2 | ₅complex | ₅relatives | ₅genetics | ₅within | ₄colitis | ₄filament | ₄severe | ₄ulcerative | ₄asca | ₄epithelial | ₄heterogeneity | ₄assembly | ₄europe | ₄genetic | ₄cd | ₃studies | ₃antibodies | ₃associated | ₃identification | ₃scottish | ₃cd14
₁₀inflammatory bowel | ₉bowel disease | ₈crohn disease | ₆nod2 card15 | ₅disease patients | ₄ulcerative colitis | ₄heterogeneity within | ₃keratin mutations | ₃card15 mutations | ₃therapy surgery | ₃scottish irish | ₃risk score | ₃evidence genetic | ₃filament assembly | ₃within europe | ₃severe ulcerative | ₃tlr4 cd14 | ₃genetic heterogeneity | ₃medical therapy | ₃second-line medical | ₃genetics inflammatory | ₂complex diseases | ₂anti-saccharomyces cerevisiae | ₂disease location | ₂disturb filament | ₂aid early | ₂first-degree relatives | ₂irish crohn | ₂early selection | ₂asca crohn | ₂selection patients | ₂outcome severe
₉inflammatory bowel disease | ₃severe ulcerative colitis | ₃heterogeneity within europe | ₃genetic heterogeneity within | ₃evidence genetic heterogeneity | ₃second-line medical therapy | ₃genetics inflammatory bowel | ₃medical therapy surgery | ₃nod2 card15 mutations | ₃bowel disease patients | ₂disease patients evidence | ₂irish crohn disease | ₂card15 tlr4 cd14 | ₂anti-saccharomyces cerevisiae antibodies | ₂aid early selection | ₂selection patients second-line | ₂antibodies asca crohn | ₂development novel risk | ₂unravelling complex genetics | ₂patients second-line medical | ₂keratin mutations disturb | ₂cd14 mutations scottish | ₂tlr4 cd14 mutations | ₂colitis development novel | ₂mutations disturb filament | ₂predicting outcome severe | ₂asca crohn disease | ₂human keratin mutations | ₂associated disease severity | ₂observed inflammatory bowel | ₂outcome severe ulcerative | ₂disturb filament assembly

Reader's Comments (0) [comments posted by readers of J Satsangi profile]